Cardinal Health is trading 6.62% up at $279.45 on November 5 after a strong fiscal Q1 2027 report.

  • Adjusted EPS of $3.26 beat estimates, and revenue reached $67.5 billion.
  • The company raised its full-year EPS outlook to $12.80–$13.00 from $12.40–$12.60.
  • Cardinal Health highlighted a planned CVS Health distribution agreement renewal through June 2032, supporting confidence in its pharmaceutical business.